FMC stock has third-quarter results scheduled November 3 ahead of Xetra open
Published on 10/21/2026 at 08:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults date and recent updates
- Fresenius Medical Care’s investor calendar schedules the third-quarter 2026 results release for November 3, 2026.
- The company’s investor-relations newsroom lists a statement dated October 20, 2026, concerning the U.S. kidney-care national plan.
- On October 19, 2026, the newsroom listed a release on research and innovation presented at ASN Kidney Week 2026.
Fresenius Medical Care’s investor-relations calendar schedules the company’s third-quarter 2026 results release for November 3, 2026, according to the company’s investor-relations page.
Results date ahead
The calendar identifies November 3, 2026, as the date for publication of the third-quarter business results and a conference call. The same investor-relations page lists a financial-reporting period from October 20 through November 2, 2026.
Recent company updates
Fresenius Medical Care’s newsroom lists an October 20, 2026, statement regarding a release by the U.S. Department of Health and Human Services on a national kidney-care plan. It also lists an October 19, 2026, release on scientific findings and innovations presented at ASN Kidney Week 2026, according to the investor-relations newsroom.
Business and market context
Fresenius Medical Care provides kidney-care and dialysis services in the healthcare market. The investor calendar lists the third-quarter results release for November 3, 2026. Market context: Market report DAX.
The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of FMC stock.
